Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-09-26
1998-02-24
Seidleck, James J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514400, 514401, 514402, A01N 4350
Patent
active
057212660
ABSTRACT:
Methods of treating proliferative diseases or viral, inflammatory, allergic and cardiovascular diseases, and restenosis are disclosed. The present invention demonstrates the use of 2-amino-1-(2-imidazolin-2-yl)-2-imidazolines, and derivatives, and salts thereof, to antagonize the association of a protein tyrosine kinase with a substrate regulatory protein. The present invention also demonstrates the use of pharmaceutical compositions employing 2-amino-1-(2-imidazolin-2-yl)-2-imidazolines, and derivatives, and salts thereof, to antagonize the association of a protein tyrosine kinase with substrate regulatory protein. The present invention also relates to novel
REFERENCES:
patent: 3840554 (1974-10-01), Wittekind et al.
patent: 3905992 (1975-09-01), Wittekind et al.
Decker Stuart James
Fry David William
Hamby James Marino
Saltiel Alan Robert
Seidleck James J.
Tinney Francis J.
Warner-Lambert & Company
Williamson Michael A.
LandOfFree
Substituted imidazolinyl-imidazolines as antagonists of SH-2 bin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted imidazolinyl-imidazolines as antagonists of SH-2 bin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imidazolinyl-imidazolines as antagonists of SH-2 bin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1875579